Annual Net Income
-$42.19 M
-$23.45 M-125.14%
31 December 2023
Summary:
SAB Biotherapeutics annual net profit is currently -$42.19 million, with the most recent change of -$23.45 million (-125.14%) on 31 December 2023. During the last 3 years, it has fallen by -$62.31 million (-309.73%). SABS annual net income is now -309.73% below its all-time high of $20.12 million, reached on 31 December 2020.SABS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$10.35 M
-$3.01 M-41.09%
30 September 2024
Summary:
SAB Biotherapeutics quarterly net profit is currently -$10.35 million, with the most recent change of -$3.01 million (-41.09%) on 30 September 2024. Over the past year, it has dropped by -$5.25 million (-102.84%). SABS quarterly net income is now -834.10% below its all-time high of $1.41 million, reached on 31 March 2021.SABS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$45.57 M
-$5.25 M-13.01%
30 September 2024
Summary:
SAB Biotherapeutics TTM net profit is currently -$45.57 million, with the most recent change of -$5.25 million (-13.01%) on 30 September 2024. Over the past year, it has dropped by -$18.36 million (-67.46%). SABS TTM net income is now -3332.19% below its all-time high of $1.41 million, reached on 31 March 2021.SABS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -125.1% | -102.8% | -67.5% |
| 3 y3 years | -309.7% | -154.8% | -714.7% |
| 5 y5 years | - | - | - |
SABS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -309.7% | at low | -1149.7% | +54.7% | -714.7% | at low |
| 5 y | 5 years | -309.7% | at low | -834.1% | +54.7% | -3332.2% | at low |
| alltime | all time | -309.7% | at low | -834.1% | +54.7% | -3332.2% | at low |
SAB Biotherapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.35 M(+41.1%) | -$45.57 M(+13.0%) |
| June 2024 | - | -$7.34 M(+46.0%) | -$40.32 M(+1.1%) |
| Mar 2024 | - | -$5.03 M(-78.0%) | -$39.87 M(-5.5%) |
| Dec 2023 | -$42.19 M(+125.1%) | -$22.86 M(+348.0%) | -$42.19 M(+55.1%) |
| Sept 2023 | - | -$5.10 M(-25.8%) | -$27.21 M(-6.8%) |
| June 2023 | - | -$6.88 M(-6.4%) | -$29.19 M(+7.8%) |
| Mar 2023 | - | -$7.35 M(-6.6%) | -$27.08 M(+44.5%) |
| Dec 2022 | -$18.74 M | -$7.87 M(+11.3%) | -$18.74 M(-16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$7.08 M(+48.2%) | -$22.42 M(+15.5%) |
| June 2022 | - | -$4.78 M(-584.4%) | -$19.40 M(+10.4%) |
| Mar 2022 | - | $985.90 K(-108.5%) | -$17.57 M(+2.5%) |
| Dec 2021 | -$17.14 M(-185.2%) | -$11.55 M(+184.4%) | -$17.14 M(+206.5%) |
| Sept 2021 | - | -$4.06 M(+38.1%) | -$5.59 M(+265.1%) |
| June 2021 | - | -$2.94 M(-308.7%) | -$1.53 M(-208.7%) |
| Mar 2021 | - | $1.41 M | $1.41 M |
| Dec 2020 | $20.12 M(-323.9%) | - | - |
| Dec 2019 | -$8.99 M | - | - |
FAQ
- What is SAB Biotherapeutics annual net profit?
- What is the all time high annual net income for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual net income year-on-year change?
- What is SAB Biotherapeutics quarterly net profit?
- What is the all time high quarterly net income for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly net income year-on-year change?
- What is SAB Biotherapeutics TTM net profit?
- What is the all time high TTM net income for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM net income year-on-year change?
What is SAB Biotherapeutics annual net profit?
The current annual net income of SABS is -$42.19 M
What is the all time high annual net income for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual net profit is $20.12 M
What is SAB Biotherapeutics annual net income year-on-year change?
Over the past year, SABS annual net profit has changed by -$23.45 M (-125.14%)
What is SAB Biotherapeutics quarterly net profit?
The current quarterly net income of SABS is -$10.35 M
What is the all time high quarterly net income for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly net profit is $1.41 M
What is SAB Biotherapeutics quarterly net income year-on-year change?
Over the past year, SABS quarterly net profit has changed by -$5.25 M (-102.84%)
What is SAB Biotherapeutics TTM net profit?
The current TTM net income of SABS is -$45.57 M
What is the all time high TTM net income for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM net profit is $1.41 M
What is SAB Biotherapeutics TTM net income year-on-year change?
Over the past year, SABS TTM net profit has changed by -$18.36 M (-67.46%)